Zhengqing Fengtongning

Developed by the research team led by Chair Prof. Liu Liang, an academician of the Chinese Academy of Engineering. Zhengqing Fengtongning is a drug from which a series of products for the treatment of rheumatoid arthritis have been developed jointly with the Hunan Zhengqing Pharmaceutical Group. The research results were awarded the State Scientific and Technological Progress Award with M.U.S.T. as the first completer, marking the first time that Macao and Hong Kong have won a national science and technology award in the research of Chinese medicine.